Skip to main content

Milestone 8.D

Initiate at least one clinical trial for primary prevention of AD and AD-related dementias among high risk individuals in midlife including a non-pharmacological treatment arm.


Success Criteria

Completion of at least one Phase II primary prevention trial for non-pharmacological interventions in midlife. Successful trials will provide evidence for potential therapeutic mechanisms and include the collection of biomarker data for future validation and longitudinal follow-up within the trial cohort.


Research Implementation Area
Non-Pharmacological Interventions
Timeline
2021–2025
Status
In Progress

Accomplishments/Implementation Activities

Research Programs and Resources

Research Highlights

Relevant Recommendations